Ann: Appendix 3B-RAP.AX, page-8

Shares seem to keep on going up in anticipation of the US trials due 3-6 months ago. Market is irrational as FDA approval without USA results seems contrary to what they specified at the pre FA meeting. Price should be marked down for nonconformance. Because I sold heaps at a massive profit last week and didn't buy at the recent lows. Well done to holders now, as chart and stock demand looks impressive and now have no chance of buying the same number that I sold.
Sitting on cash profits looking for another RAP is just not the same. Hope u people don't mind this reminder of USA trials not being met in due time for FDA approval before EOY as the market has totally ignored it.